Savara (SVRA) Times Interest Earned (2011 - 2018)
Savara (SVRA) reported Times Interest Earned of -$105.36 for Q2 2018, down 481.9% year-over-year from $27.59 in Q2 2017, and up 65.87% on a QoQ basis from -$308.72 in Q1 2018.
Savara (SVRA) has 6 years of Times Interest Earned data on file, last reported at -$105.36 in Q2 2018.
- Quarterly Times Interest Earned fell 481.9% year-over-year to -$105.36 in Q2 2018, while the trailing twelve-month figure through Mar 2019 was -$450.07 (down 701.33% YoY) and the FY2017 annual result came in at -$25.8, down 6.53% from the prior year.
- Times Interest Earned advanced to -$105.36 in Q2 2018 per SVRA's latest filing, from -$308.72 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$3.26 in Q1 2016 and bottomed at -$10181.0 in Q2 2015.
- The 4-year median for Times Interest Earned is -$23.62 (2017), against an average of -$857.93.
- The widest annual swing landed in 2016, when Times Interest Earned jumped 97.22%; it then plunged 1484.35% in 2018.
- Tracing SVRA's Times Interest Earned over 4 years: stood at -$3.91 in 2015, then slumped by 321.91% to -$16.51 in 2016, then slumped by 357.87% to -$75.58 in 2017, then plunged by 39.41% to -$105.36 in 2018.
- Per Business Quant, the three latest SVRA Times Interest Earned figures stand at -$105.36 (Q2 2018), -$308.72 (Q1 2018), and -$75.58 (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -105.36 |
| Mar 31, 2018 | -308.72 |
| Dec 31, 2017 | -75.58 |
| Sep 30, 2017 | -23.62 |
| Jun 30, 2017 | -18.11 |
| Mar 31, 2017 | -19.49 |
| Dec 31, 2016 | -16.51 |
| Sep 30, 2016 | -17.00 |
| Jun 30, 2016 | -283.29 |
| Mar 31, 2016 | -3.26 |
| Dec 31, 2015 | -3.91 |
| Sep 30, 2015 | -97.31 |
| Jun 30, 2015 | -10,181.00 |
| Mar 31, 2012 | -389.50 |
| Dec 31, 2011 | -227.52 |
| Sep 30, 2011 | -13,061.93 |